Latest and live tenders published in all country. Click on any tender to view further details.

feathertop rhodes grass is a highly aggressive weed that, despite being a focus of several research efforts, is continuing to increase in incidence and severity in northern farming systems. the recent confirmation of resistance to glyphosate also highlights the need to manage the weed with an integrated systems approach. this proposal builds on work in daq00105, us00084, and nga00004 that have investigated various strategies for managing feathertop rhodes grass in the summer/winter cropping areas of the northern region. to facilitate improved management of feathertop rhodes grass in queensland and northern nsw, a communication and extension campaign is required. the procurement will update the current feathertop rhodes grass integrated weed management iwm publication for winter/summer cropping areas by incorporating recent research results and will be used as the focus of a targeted extension campaign. in the winter cropping areas of southern nsw, research is required to develop a locally adapted feathertop rhodes grass iwm plan for the prevailing farming system. this should be based on the existing iwm plan but will need to address: differences in the value of residual herbicides based on the presence of sandy, acidic, low oc soils, lower and winter dominant rainfall and crop choice taking into account possible product registration opportunities. differences in the effectiveness of cultivation based on soil type. use of site-specific weed management. opportunities for management in the pasture phase e.g. chemical options and with grazing as a first step in a double knock and the impact of livestock on both spread and/or control of the weed e.g. livestock field preference and feathertop rhodes grass regrowth. extension of this work to growers in southern nsw is a key component of this procurement. project description this investment consists of two interrelated procurements. the applicant may apply for one, or both the procurements proc-9176001 program 2 and this one. where only one of the procurements is applied for, applicants should demonstrate how they will link with the corresponding program. this investment program 1 will: 1. update the iwm plan for feathertop rhodes grass originally released in 2014 and use targeted extension and communication strategies to facilitate adoption of it in northern nsw and queensland. applications should clearly demonstrate how the proposed program will cover the entire winter/summer cropping belt of northern nsw and queensland. expected outcome by june 2024, the extent and impact of feathertop rhodes grass on grain yield in the northern region will be reduced through growers implementing integrated weed management strategies. expected outputs output 1 by december 2019, an updated iwm strategy for feathertop rhodes grass available for growers and advisers in northern new south wales and queensland details: scope to be based on the daf publication integrated weed management of feathertop rhodes grass 2014 but should include new research where relevant output 2 by june 2021, an extension package to facilitate adoption of the iwm strategy for feathertop rhodes grass developed and delivered in northern nsw and queensland details: extension package may include demonstrations sites, field walks and communication products.

feathertop rhodes grass is a highly aggressive weed that, despite being a focus of several research efforts, is continuing to increase in incidence and severity in northern farming systems. the recent confirmation of resistance to glyphosate also highlights the need to manage the weed with an integrated systems approach. this proposal builds on work in daq00105, us00084, and nga00004 that have investigated various strategies for managing feathertop rhodes grass in the summer/winter cropping areas of the northern region. to facilitate improved management of feathertop rhodes grass in queensland and northern nsw, a communication and extension campaign is required. the procurement will update the current feathertop rhodes grass integrated weed management iwm publication for winter/summer cropping areas by incorporating recent research results and will be used as the focus of a targeted extension campaign. in the winter cropping areas of southern nsw, research is required to develop a locally adapted feathertop rhodes grass iwm plan for the prevailing farming system. this should be based on the existing iwm plan but will need to address: 1. differences in the value of residual herbicides based on the presence of sandy, acidic, low oc soils, lower and winter dominant rainfall and crop choice taking into account possible product registration opportunities 2. differences in the effectiveness of cultivation based on soil type 3. use of site-specific weed management 4. opportunities for management in the pasture phase e.g. chemical options and with grazing as a first step in a double knock and 5. the impact of livestock on both spread and/or control of the weed e.g. livestock field preference and feathertop rhodes grass regrowth. extension of this work to growers in southern nsw is a key component of this procurement.

supply of production of high value, human consumption pulses in australia is dominated by lentil and chickpea, and is concentrated on the more fertile soils in the medium rainfall areas of the southern and northern regions. due to the farming system benefits of imposing a double break and the high prices in recent years, there is much interest in expanding lentil and chickpea production onto soils with a number of constraints acidity, nutrient toxicities and deficiencies, poor structure and into other rainfall zones. it is critical that new pulses be developed and managed such that the crop life-cycle fits within the constraints of availability of soil water, frost and heat stresses and flowering and pod-set occur in the optimum window for different agroecological zones. as time to flowering and pod-set are so critical in these crops, understanding and improving them in existing production regions and where they have not been optimised yet is one of the most critical elements that can contribute to their adoption and deliver potential step changes in yield and profit. the national pulse phenology investment proposed will utilise common genetic resources across existing and potential pulse expansion regions of australia to expedite delivery of data, tools and knowledge which can inform crop breeding. it will leverage international r&d activities, and new synergies provided by recent developments in understanding of genome synteny and conserved pathways in this group of crops to deliver on investment outputs.

recent incursion of the barley disease ramularia has not been fully delimited around the areas of confirmed occurrence. as this disease can spread through infected seed, growers in these regions will need information on the relative risk of saving seed for planting the following year. other regions that currently have had no positive recordings will need to be surveyed to ensure that these areas are currently free from ramularia. ramularia in the northern hemisphere and new zealand has recently increased in pathogen aggressiveness, decreased in fungicide sensitivity and caused epidemics in germany. determining the occurrence of ramularia across the australian grain belt will inform the level of disease management options required including seed hygiene, fungicide and pre-breeding investments.

falling number fn is a global industry standard used to quantify detrimental pre-harvest sprouting phs in wheat, as early release from seed dormancy leads to significant effects on end product quality. however, a low falling number can also be caused by the trait of late maturity alpha-amylase lma, with some wheats having a genetic predisposition to accumulate low levels of starch digesting enzymes during grain filling in the absence of sprouting. lma susceptibility is currently a classification criterion for milling wheat in australia. due to the cost involved in the current lma susceptibility screen, it is currently employed at a late phase in the breeding pathway of australian wheat breeding programs, which significantly restricts genetic gains for yield and other traits in australian wheat varieties.

falling number fn is a global industry standard used to quantify detrimental pre-harvest sprouting phs in wheat, as early release from seed dormancy leads to significant effects on end product quality. however, a low falling number can also be caused by the trait of late maturity alpha-amylase lma, with some wheats having a genetic predisposition to accumulate low levels of starch digesting enzymes during grain filling in the absence of sprouting. lma susceptibility is currently a classification criterion for milling wheat in australia.

supply of products under the rehabilitation appliances program rap as listed in the rap national schedule of equipment. this rft seeks to establish a standing offer panel comprising suitable organisations to provide continence and other products to entitled persons throughout australia, including those who reside in major cities, inner and outer regional areas, and remote or very remote areas. dva encourages tenders from suitable organisations that have the capability to supply the specified products to entitled persons throughout australia. through the rft, dva intends to engage organisations with a demonstrated capability to flexibly provide quality services that meet the needs of dva. note: tenderers should ensure all tender documentation is uploaded to the correct austender atm id.

suitably qualified organisations to participate in a potential multi-stage procurement process for the provision of innovative solutions to enhance the department’s unified communications.

cancer burden and there are more than 100 types of brain cancer and other central nervous system cancers. these cancers carry high rates of morbidity and mortality. the five-year relative survival rate for brain cancer is low, at around 22 per cent. the young are disproportionately affected by brain cancer and brain cancer kills more children in australia than any other disease. despite improvements in patient care and support, survival rates for brain cancer have remained relatively unchanged for the past 30 years. the australian brain cancer mission the mission was announced on 29 october 2017 and aims to double survival rates and improve the quality of life for patients with brain cancer over ten years to 2027, with the longer term aim of defeating brain cancer. as at july 2019, $124.7m had been committed to the mission through co-investments from philanthropy, non-government organisations and governments, including $58.35m from the australian government through the medical research future fund mrff. cancer australia is responsible for administering the mission, supported by a strategic advisory group msag. a national brain cancer research roundtable was convened in 2017 bringing together people affected by brain cancer and their families, leading australian and international researchers, clinicians, advocacy and philanthropic groups. this roundtable provided the framework for delivery on the aim of the mission and developed a research roadmap that articulates the mission’s investment strategies. conducting an ‘analysis of australian brain cancer platforms and technologies’ is one of the early and immediate priorities for implementation outlined in the research roadmap. the purpose of the analysis is to inform future national infrastructure requirements and their use; identify networking strategies to enhance utilisation for platform and technology systems, and reduce duplication in effort; facilitate better coordinated use of platforms and technologies which will play a significant role in supporting brain cancer research, clinical trials, early detection, diagnosis, treatment and clinical care for children, adolescents and young adults aya, and adults with brain cancer for the next 3 – 5 years, and to 2027. scope: the scope of the analysis will cover platforms and technologies applicable to children, aya and adults with brain cancer across the brain cancer continuum of care, which for the analysis, will include brain cancer research, clinical trials, early detection, diagnosis, treatment, and clinical care. outcomes and reporting requirements: the analysis will inform future national infrastructure requirements, including how resources can be coordinated to play a significant role in supporting the brain cancer continuum of care for children, aya, and adults. the analysis will also identify existing platforms and technologies, as well as potential new platforms and technologies. in undertaking this work, the contractor will be required to provide cancer australia with monthly updates by teleconference, two progress reports, a draft final report and a final report. the two progress reports, the draft final report and the final report will also be considered by msag. the final report will include: 1.a review outlining brain cancer platforms and technologies that are currently available nationally and internationally, and how they are being used in australia; 2.a review of platforms and technologies currently used in cancer research and clinical trials, and where relevant, how these platforms and technologies can be incorporated across the brain cancer continuum of care to inform potential future investments under the mission over the next 3 - 5 years; and to 2027; 3.a review and the analysis of consultations with relevant experts identifying current platforms and technologies, and potential new platforms and technologies, that could inform the next investments under the mission to support the brain cancer continuum of care in australia, specifically: a. what is needed over the next 3 - 5 years; and b. what is on the horizon to 2027; and 4.an analysis of consultations with relevant experts identifying the workforce requirements, capacity, capability and training needs for the next 3 - 5 years and up to 2027, to support future investments in brain cancer platforms and technologies. 5.a gap analysis to inform future requirements across the brain cancer continuum of care in the next 3 – 5 years, and to 2027. the gap analysis will include: a.approaches to enhance utilisation of platform and technology system networks; b.proposals for how current and potential new platforms and technologies utilising large data sets and bioinformatics, can aid in achieving the aim of the mission; c.potential strategies for reduction of any identified duplications in resources in relation to brain cancer platforms and technologies across the continuum of care; and d.potential strategies to facilitate more efficient coordinated use of brain cancer platforms and technologies. 6.a cost-benefit analysis for upscaling current platforms and technologies, and introducing potential new platforms and technologies, to fill identified validated gaps from the above gap analysis. the cost-benefit analysis will include the costs and benefits to patients and the healthcare system in the next 3 – 5 years, and up to 2027, to inform potential future investments under the mission. 7.a plan for upscaling existing platforms and technologies, and the introduction of potential new platforms and technologies, including considerations for the identified critical parameters and elements, required for the upscaling and introduction of these platforms and technologies, to achieve expansion of the brain cancer continuum of care in the next 3 – 5 years and up to 2027. partnerships: cancer australia encourages the partnering of different organisations, departments, and groups to bring together the necessary skills and experiences to provide a tender to undertake the analysis. the organisational structure and management of staff involved in the partnership should be outlined in the tender. timeframe: the project is planned to commence in november 2019 and to be completed within six months of the start date. funding of up to $450, 000 gst inclusive has been provided from the department of health to cancer australia for the purpose of procuring a suitably qualified organisation to undertake this work.

provision of internal audit services, further details of the requirement are set out in schedule 1 statement of requirement.